[ad_1]
In today’s Guardian, it is announced that computer scientists and cancer specialists have used artificial intelligence (AI) to determine that the combination of the drugs Everolimus and Vandetanib could treat the deadly pediatric brain tumor, pontine glioma. diffuse intrinsic (DIPG).
This form of brain cancer has not seen improved survival rates for more than half a century, but the breakthrough – as the journal Cancer Discovery reports – is expected to usher in a “exciting” new era where AI can be harnessed to invent and develop new treatments for all types of cancer, experts say.
After analyzing data on existing drugs at the Institute of Cancer Research (ICR) in London, a team of scientists, doctors and data analysts found that everolimus may improve the ability of vandetanib to “sneak” across the blood brain barrier and treat cancer.
This could become one of the first examples of a treatment offered by AI to benefit patients.
Testing has already started on a small number of children, and experts now hope to test it on a much larger group of children in major clinical trials.
This is especially welcome news in September as it is Pediatric Cancer Awareness Month and Brain Tumor Research took the opportunity to raise awareness about brain tumors, the deadliest cancer in children.
Associated reading:
If you found this story interesting or useful, subscribe to our weekly e-news and stay up to date with all the latest news from Brain Tumor Research.
[ad_2]
Source link
